E. Razis
Impact in
-
- Ovarian cancer diagnosis and treatment
-
- Glioma Diagnosis and Treatment
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- HER2/EGFR in Cancer Research 3
-
- Cancer Genomics and Diagnostics 4
- Breast Cancer Treatment Studies 3
- Co-authors
- George Fountzilas (14 shared papers)Gerasimos Aravantinos (7 shared papers)Abraham Mittelman (1 shared paper)Maria Karina (1 shared paper)Anna Kalogera‐Fountzila (1 shared paper)Mattheos Bobos (4 shared papers)Michail Ignatiadis (1 shared paper)Dimitrios Pectasides (4 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Annals of Oncology (2 papers)Anticancer Research (1 paper)European Journal of Cancer (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- GreeceUnited StatesGermany
In The Last Decade
E. Razis
17 papers receiving 76 citations
Peers
Comparison fields: 5 of 28
- Reproductive Medicine 14
- Genetics 17
- Oncology 19
- Pulmonary and Respiratory Medicine 16
- Cancer Research 7
Countries citing papers authored by E. Razis
This map shows the geographic impact of E. Razis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Razis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Razis more than expected).
Fields of papers citing papers by E. Razis
This network shows the impact of papers produced by E. Razis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Razis. The network helps show where E. Razis may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Razis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study. | 2005 | 20 |
| 2 | Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation. | 2007 | 20 |
| 3 | 1994 | 8 | |
| 4 | 2020 | 6 | |
| 5 | 2007 | 5 | |
| 6 | 2004 | 3 | |
| 7 | 2018 | 3 | |
| 8 | 2004 | 2 | |
| 9 | 2007 | 1 | |
| 10 | 2006 | 1 | |
| 11 | 2016 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2010 | 1 | |
| 16 | 2013 | 1 | |
| 17 | Technology evaluation: TriGem, Titan. | 2003 | 1 |
| 18 | 2024 | 0 | |
| 19 | 2014 | 0 | |
| 20 | 2016 | 0 |
About E. Razis
E. Razis is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 20 papers that have together received 76 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Cancer Genomics and Diagnostics (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers), Glioma Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Reproductive Medicine (14 citations), Genetics (17 citations), Oncology (19 citations), Pulmonary and Respiratory Medicine (16 citations) and Cancer Research (7 citations). E. Razis has collaborated with scholars based in Greece, United States and Germany. Frequent co-authors include George Fountzilas, Gerasimos Aravantinos, Abraham Mittelman, Maria Karina, Anna Kalogera‐Fountzila, Mattheos Bobos, Michail Ignatiadis, Dimitrios Pectasides, Helen Gogas and P. Kosmidis. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Anticancer Research, European Journal of Cancer and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.